OCRF//X
Jun 11, 2025, 17:07
Donate Today and Fund the Science That Changes Lives – Ovarian Cancer Research Foundation
Ovarian Cancer Research Foundation (OCRF) shared a post on LinkedIn:
“Granulosa Cell Tumours(GSTs) are rare (just 5–8% of ovarian cancer cases) but their impact can last a lifetime. These tumours often return years after treatment, leaving women in a constant state of fear and uncertainty.
But thanks to your support, that story is finally starting to change.
For 25 years, Associate Professor Simon Chu has made it his life’s work to understand and treat GCTs. With OCRF’s support starting from his very first PhD scholarship, Assoc Prof Chu and his team are now close to developing new effective treatments that could offer women with granulosa cell tumours real hope for the future.
Your donation before 30 June keeps that momentum going.
It helps ensure that no woman is left behind, no matter how rare her diagnosis.
Donate today and fund the science that changes lives.”
More posts featuring Ovarian Cancer Research Foundation on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 11, 2025, 13:48